Table V.
Summary of functional outcome measures.
| Functional outcome measure | No. of studies | ROM (degrees [95% CI]) | Heterogeneity |
|
|---|---|---|---|---|
| I2 (%) | P value | |||
| Group MD | ||||
| ASES – difference | 4 | 44.11 (29.54, 58.68) | 0.0 | .987 |
| CMS – difference | 10 | 42.04 (38.75, 45.32) | 0.0 | .922 |
| VASP – difference | 6 | −5.60 (−6.92, −4.27) | 0.0 | .612 |
| SST – difference | 3 | 3.93 (−0.43, 8.30) | 65.9 | .053 |
| Group MD – CTA | ||||
| CMS – difference | 5 | 43.38 (39.68, 47.09) | 0.0 | .697 |
| Group LD | ||||
| ASES – difference | 5 | 43.47 (30.09, 56.84) | 0.0 | .999 |
| CMS – difference | 4 | 41.14 (35.35, 46.92) | 32.1 | .195 |
| VASP – difference | 7 | −6.08 (−7.99, −4.17) | 56.6 | .018 |
| SST – difference | 4 | 4.98 (2.95, 7.00) | 0.0 | .915 |
| Group LD – CTA | ||||
| CMS – difference | 3 | 41.49 (34.93, 48.05) | 45.6 | .118 |
ASES, American Shoulder and Elbow Surgeons scoring system; CMS, Constant Murley score; CTA, cuff tear arthropathy; LD, lateralized design; MD, medialized design; VASP, VAS score for pain.
ROM is shown as mean (95% confidence interval).